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Automated Hovering in Health Care — Watching Over the 5000 Hours
Abstract
The dominant form of health care financing in the United States supports a reactive, visit-based model in
which patients are seen when they become ill, typically during hospitalizations and at outpatient visits.
That care model falls short not just because it is expensive and often fails to proactively improve health,
but also because so much of health is explained by individual behaviors,1 most of which occur outside
health care encounters. Indeed, even patients with chronic illness might spend only a few hours a year
with a doctor or nurse, but they spend 5000 waking hours each year engaged in everything else —
including deciding whether to take prescribed medications or follow other medical advice, deciding what
to eat and drink and whether to smoke, and making other choices about activities that can profoundly
affect their health.
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T

he dominant form of health care financing in
the United States supports a reactive, visitbased model in which patients are seen when they
become ill, typically during hospitalizations and at

outpatient visits. That care model
falls short not just because it is
expensive and often fails to proactively improve health, but also
because so much of health is explained by individual behaviors,1
most of which occur outside
health care encounters. Indeed,
even patients with chronic illness
might spend only a few hours a
year with a doctor or nurse, but
they spend 5000 waking hours
each year engaged in everything
else — including deciding whether to take prescribed medications
or follow other medical advice, deciding what to eat and drink and
whether to smoke, and making
other choices about activities that
can profoundly affect their health.

The increasing attention being
paid to those 5000 hours takes
various forms. Employers are focusing more on employees’ wellness — how they eat, whether
they smoke, and how much they
exercise. Medication adherence has
become a more important goal,
thanks to growing recognition
that many people with chronic
conditions fail to take their medications regularly and therefore do
not get the benefits that health
care can provide. Home-based biometric assessments of indicators
such as glucose level, blood pressure, and weight are emerging as
part of longitudinal clinical care.
Transitional care models are being touted as a way of coordinatn engl j med 367;1

nejm.org

ing care beyond hospitalization.
And hospitals and health plans
are developing “hot-spotter” approaches, deploying tailored and
intensive attention to managing
the care of their most challenging patients.2 All these activities
occur outside the conventional,
billable, clinical encounter — and
all reflect some sort of hovering
over people in their daily lives.
Conventional approaches to improving patient engagement along
these dimensions have been personnel-intensive — using visiting
nurses or clinically staffed telemedicine services. Although results have been mixed, in general
these programs have not fulfilled
their promise. One problem is
that using personnel in hovering
is expensive and therefore difficult to scale up and to justify, except for the very sickest patients,
some of whom might be too sick
to benefit. Another problem is
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that initiating and maintaining
patient engagement is difficult.
A large multicenter trial of telemonitoring for patients with heart
failure showed no effect on the
primary outcomes of rehospitalization and death; moreover, 14%
of those assigned to the intervention group would not use the
system at all, and nearly half of
those who did lost interest over
time. One challenge, therefore, is
finding a way to automate hovering to reduce its cost. A related
challenge is figuring out how to
incorporate it into people’s lives
in ways that are not just acceptable and convenient, but ideally
even welcomed.
Three recent developments suggest that automated hovering may
offer promise. First are early efforts at payment mechanisms that
support more accountability for
health outcomes — including
nonreimbursement for preventable readmissions and bundling of
payments around the goals of care
rather than encounters. These
changes provide a financial engine to support automated hovering initiatives.
The second development is
our deepening understanding of
behavioral economics and the reality that although most people
want better health and typically
know what it would take to
achieve it, the desires, distractions,
and urgencies of the moment often get in the way of pursuing
what’s in their own long-term
self-interest. Behavioral economics explains why people are predictably irrational and provides
tools for redirecting their behavior with carefully deployed nudges and financial incentives.3
The third development is the
expanded reach of both sophisticated and simple technologies —
cell phones, wireless devices, and
2
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the Internet — that can help
health experts connect to people
during their everyday lives. Neither wireless devices nor behavioral economics were part of the
disease-management programs
that have produced mixed results
in the past.
There is already considerable
evidence of the promise of automated hovering. One study of patients taking warfarin deployed a
home-based pill dispenser that
was electronically tethered to a
lottery system. Patients were automatically entered into a daily
random drawing, with a small
chance of winning $100 and a
larger chance of winning $10.
Each day, patients were electronically notified if their number had
come up — which it would do
about 1 day in 5 — but were eligible for the prize only if they
had taken their warfarin the previous day, as signaled by the dispenser. The system provided daily
engagement, the chance of a prize,
and a sense of anticipated regret:
no one wants to receive news of
winning only to be disqualified
for nonadherence the previous day.
The expected value of the lottery
was less than $3 per day, but the
system reduced the rate of incorrect doses from 22% to about 3%
and reduced the rate of out-ofrange international normalized
ratios from 35% to 12%.4 Such a
system could easily be deployed
to improve medication adherence
among patients discharged from
the hospital with congestive heart
failure or after being treated for
acute coronary syndromes. This
system uses technology with an
engagement strategy informed by
behavioral economics to hover
over patients.
In another clinical trial, patients with difficult-to-control diabetes were randomly assigned to
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receive usual care or mentorship
from another patient who had
previously managed to tame his
or her own diabetes. The mentor
merely had to call the patient once
a week. The result at 6 months was
glycated hemoglobin levels more
than a full percentage point lower
than those in the control group,
created by a system requiring
minimal technology to produce
hovering that was “automatic”
from the clinician’s perspective.5
This kind of hovering must be
targeted to the right clinical and
social circumstances. The biggest
savings will probably come from
reducing preventable hospitalizations or delaying entrance into
nursing homes, because that’s
where so much spending currently occurs. However, cell-phone
mentors and automatic pill-bottle reminders probably won’t offer much to patients who are frequently hospitalized owing to a
combination of severe illness and
challenging life circumstances.
These patients, at one end of the
spectrum of intensity of health
care needs, require a more personnel-intensive approach that focuses as much on social circumstances as on complex medical
care. The best targets for automated hovering are conditions
whose management depends substantially on individual patients’
behavior. Good targets are medication adherence in patients with
heart failure or acute coronary
syndromes and efforts to manage
diet, exercise, or weight. The
amount of hovering required to
engage patients in healthy behaviors during those 5000 hours will
depend critically on the intensity
of their needs, but automated
systems might be a cost-effective
solution for many patients.
There are potential concerns.
Some people might worry that
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too much hovering will erode patients’ sense of personal responsibility or that hovering in one
area might distract providers or
patients from other important
health issues. Others may worry
that hovering is too intrusive or
paternalistic — though patients
could easily opt out, and it’s arguably no more paternalistic than
traditional approaches to improving patient outcomes. It will be
important to ensure that new
hovering efforts are evaluated
carefully, with assessment of both
intended and potential unintended consequences.
And of course, there is a considerable amount we don’t know
about these approaches: the kinds
of patients, conditions, or settings for which they will be the
most useful; the organizations
(hospitals, employers, or insurers) that should be the ones to
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deploy them; and how to make
them heard over the din of everything else that competes for attention while remaining unintrusive
enough that nudges don’t become
self-defeating nags. There are both
clinical and research opportunities
in pursuing an approach that is
just as rigorous as our approach
to other areas of medicine. Careful iterative testing is essential
because these new forms of patient engagement, whatever shape
they take, will be central to improving population health in our
future health care system.
Disclosure forms provided by the authors
are available with the full text of this article
at NEJM.org.
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Geographic Variation in Access to Care — The Relationship
with Quality
David C. Radley, Ph.D., M.P.H., and Cathy Schoen, M.S.

T

hree decades of research focused predominantly on
costs and the use of services
among Medicare beneficiaries
has repeatedly found wide regional variations in health care
experiences and health system
performance.1 Much less attention has been paid to variations
in access to care and their associated implications for quality of
care and health outcomes. Our recent Commonwealth Fund report,
“Rising to the Challenge: Results
from a Scorecard on Local Health
System Performance,”2 shows that
when we look beyond state averages, there are staggeringly wide

gaps in people’s ability to gain access to care in different communities around the country. We
also find a strong and persistent
association between access and
health care quality, including the
receipt of preventive care.
Simply put, where a person
lives matters — it influences the
ability to obtain health care, as
well as the probable quality of
care that will be received —
though it should not matter in an
equitable health care system. This
and other Scorecard findings have
important implications that are
relevant to national policy reforms
and to newly available resources
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for improving access and quality
of care.
The Scorecard tracks 43 health
system performance measures
grouped into four dimensions:
access, prevention and treatment,
potentially avoidable hospital use
and cost, and healthy lives. The
analysis examined the range of
variation across all 306 hospital
referral regions (HRRs) — regional health care markets defined
with the use of patient-flow data
for the Dartmouth Atlas of Health
Care — and drew largely from
publicly available data, generally
from 2008 to 2010. (See the Supplementary Appendix, available
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